References
- Taye H, Kabthymer RH, Hailu S, et al. Previous adverse pregnancy events as a predictor of gestational diabetes mellitus in Southern Ethiopia: a case control study. Curr Med Res Opin. 2022;38(7):1259–1266.
- Poblete JA, Olmos P. Obesity and gestational diabetes in pregnant care and clinical practice. CVP. 2020;19(2):154–164.
- Sobrevia L. Diabetes and obesity in pregnancy: from patients to molecular mechanisms. Curr Vasc Pharmacol. 2021;19(2):111–112.
- Bedell S, Hutson J, de Vrijer B, et al. Effects of maternal obesity and gestational diabetes mellitus on the placenta: current knowledge and targets for therapeutic interventions. Curr Vasc Pharmacol. 2021;19(2):176–192.
- Espinoza C, Fuenzalida B, Leiva A. Increased fetal cardiovascular disease risk: potential synergy between gestational diabetes mellitus and maternal hypercholesterolemia. Curr Vasc Pharmacol. 2021;19(6):601–623.
- Fowden AL, Camm EJ, Sferruzzi-Perri AN. Effects of maternal obesity on placental phenotype. Curr Vasc Pharmacol. 2021;19(2):113–131.
- Briana DD, Germanou K, Boutsikou M, et al. Potential prognostic biomarkers of cardiovascular disease in fetal macrosomia: the impact of gestational diabetes. J Matern Fetal Neonatal Med. 2018;31(7):895–900.
- Briana DD, Papastavrou M, Boutsikou M, et al. Differential expression of cord blood neurotrophins in gestational diabetes: the impact of fetal growth abnormalities. J Matern Fetal Neonatal Med. 2018;31(3):278–283.